Robust BRCA1-like classification of copy number profiles of samples repeated across different datasets and platforms

Molecular Oncology

Volumn 9, Issue 7, 2015, Pages 1274-1286

  Schouten, Philip C ^a   Grigoriadis, Anita ^b   Kuilman, Thomas ^a   Mirza, Hasan ^b   Watkins, Johnathan A ^b   Cooke, Saskia A ^b   van Dyk, Ewald ^a   Severson, Tesa M ^a   Rueda, Oscar M ^c   Hoogstraat, Marlous ^a,d,e   Verhagen, Caroline V M ^a   Natrajan, Rachael ^f   Chin, Suet Feung ^c   Lips, Esther H ^a   Kruizinga, Janneke ^a   Velds, Arno ^a   Nieuwland, Marja ^a   Kerkhoven, Ron M ^a   Krijgsman, Oscar ^a   Vens, Conchita ^a   Peeper, Daniel ^a   Nederlof, Petra M ^a   Caldas, Carlos ^c,g,h   Tutt, Andrew N ^b   Wessels, Lodewyk F ^a,i   Linn, Sabine C ^a,d   more..

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b GUY S HOSPITAL   (United Kingdom)

^c CANCER RESEARCH UK CAMBRIDGE RESEARCH INSTITUTE   (United Kingdom)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e Netherlands Center for Personalized Cancer Treatment   (Netherlands)

^f INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^g UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^h CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

ⁱ Department of Microelectronics   (Netherlands)

Author keywords

BRCA1; Breast cancer; Classification; Copy number aberration profiles

Indexed keywords

BRCA1 PROTEIN;

ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; BREAST CANCER; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; COPY NUMBER VARIATION; DATA PROCESSING; GENE MAPPING; GENE MUTATION; HUMAN; HUMAN TISSUE; NEXT GENERATION SEQUENCING; PRIORITY JOURNAL; PROMOTER REGION; BREAST TUMOR; COHORT ANALYSIS; DNA METHYLATION; FEMALE; GENE DOSAGE; GENETICS; INFORMATION PROCESSING; RANDOMIZED CONTROLLED TRIAL (TOPIC); TUMOR SUPPRESSOR GENE;

BACTERIA (MICROORGANISMS);

BREAST NEOPLASMS; COHORT STUDIES; COMPARATIVE GENOMIC HYBRIDIZATION; DATASETS AS TOPIC; DNA METHYLATION; FEMALE; GENE DOSAGE; GENES, BRCA1; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84938200669     PISSN: 15747891     EISSN: 18780261     Source Type: Journal    
DOI: 10.1016/j.molonc.2015.03.002     Document Type: Article

References (45)

1. Aboyoun P., Pages H., Lawrence M. GenomicRanges: Representation and Manipulation of Genomic Intervals. R Package Version 1.12.5 2013.
2. Alvarez S., Diaz-Uriarte R., Osorio A., Barroso A., Melchor L., Paz M.F., Honrado E., Rodríguez R., Urioste M., Valle L., Díez O., Cigudosa J.C., Dopazo J., Esteller M., Benitez J. A predictor based on the somatic genomic changes of the BRCA1/BRCA2 breast cancer tumors identifies the non-BRCA1/BRCA2 tumors with BRCA1 promoter hypermethylation. Clin. Cancer Res. 2005, 11:1146-1153.
3. Baumbusch L.O., Aarøe J., Johansen F.E., Hicks J., Sun H., Bruhn L., Gunderson K., Naume B., Kristensen V.N., Liestøl K., Børresen-Dale A.-L., Lingjaerde O.C. Comparison of the Agilent, ROMA/NimbleGen and Illumina platforms for classification of copy number alterations in human breast tumors. BMC Genomics 2008, 9:379.
4. Bengtsson H., Irizarry R., Carvalho B., Speed T.P. Estimation and assessment of raw copy numbers at the single locus level. Bioinforma 2008, 24:759-767.
5. Benjamini Y., Speed T.P. Summarizing and correcting the GC content bias in high-throughput sequencing. Nucleic Acids Res 2012, 40:e72. 10.1093/nar/gks001.
6. Buffart T.E., Israeli D., Tijssen M., Vosse S.J., Mrsić A., Meijer G.A., Ylstra B. Across array comparative genomic hybridization: a strategy to reduce reference channel hybridizations. Genes Chromosomes Cancer 2008, 47:994-1004.
7. Cancer Genome Atlas Network Comprehensive molecular portraits of human breast tumours. Nature 2012, 490:61-70.
8. Curtis C., Lynch A.G., Dunning M.J., Spiteri I., Marioni J.C., Hadfield J., Chin S.-F., Brenton J.D., Tavaré S., Caldas C. The pitfalls of platform comparison: DNA copy number array technologies assessed. BMC Genomics 2009, 10:588.
9. Curtis C., Shah S.P., Chin S.-F., Turashvili G., Rueda O.M., Dunning M.J., Speed D., Lynch A.G., Samarajiwa S., Yuan Y., Gräf S., Ha G., Haffari G., Bashashati A., Russell R., McKinney S., Langerød A., Green A., Provenzano E., Wishart G., Pinder S., Watson P., Markowetz F., Murphy L., Ellis I., Purushotham A., Børresen-Dale A.-L., Brenton J.D., Tavaré S., Caldas C., Aparicio S. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature 2012, 486:346-352.
10. De Ronde J., Klijn C., Velds A. KCsmart: Multi Sample ACGH Analysis Package Using Kernel Convolution 2009, http://www.bioconductor.org/packages/release/bioc/html/KCsmart.html.
11. Bernstein B.E., Birney E., Dunham I., Green E.D., Gunter C., Snyder M. An integrated encyclopedia of DNA elements in the human genome. Nature 2012, 489:57-74. ENCODE Project Consortium.
12. Esteller M., Silva J.M., Dominguez G., Bonilla F., Matias-Guiu X., Lerma E., Bussaglia E., Prat J., Harkes I.C., Repasky E.A., Gabrielson E., Schutte M., Baylin S.B., Herman J.G. Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors. J. Natl. Cancer Inst. 2000, 92:564-569.
13. Harakalova M., Mokry M., Hrdlickova B., Renkens I., Duran K., van Roekel H., Lansu N., van Roosmalen M., de Bruijn E., Nijman I.J., Kloosterman W.P., Cuppen E. Multiplexed array-based and in-solution genomic enrichment for flexible and cost-effective targeted next-generation sequencing. Nat. Protoc. 2011, 6:1870-1886. 10.1038/nprot.2011.396.
14. Hester S.D., Reid L., Nowak N., Jones W.D., Parker J.S., Knudtson K., Ward W., Tiesman J., Denslow N.D. Comparison of comparative genomic hybridization technologies across microarray platforms. J. Biomol. Tech. 2009, 20:135-151.
15. Joosse S.A., Brandwijk K.I.M., Devilee P., Wesseling J., Hogervorst F.B.L., Verhoef S., Nederlof P.M. Prediction of BRCA2-association in hereditary breast carcinomas using array-CGH. Breast Cancer Res. Treat 2012, 132:379-389.
16. Joosse S.A., Brandwijk K.I.M., Mulder L., Wesseling J., Hannemann J., Nederlof P.M. Genomic signature of BRCA1 deficiency in sporadic basal-like breast tumors. Genes. Chromosomes Cancer 2011, 50:71-81.
17. Joosse S.A., van Beers E.H., Nederlof P.M. Automated array-CGH optimized for archival formalin-fixed, paraffin-embedded tumor material. BMC Cancer 2007, 7:43.
18. Joosse S.A., van Beers E.H., Tielen I.H.G., Horlings H., Peterse J.L., Hoogerbrugge N., Ligtenberg M.J., Wessels L.F.A., Axwijk P., Verhoef S., Hogervorst F.B.L., Nederlof P.M. Prediction of BRCA1-association in hereditary non-BRCA1/2 breast carcinomas with array-CGH. Breast Cancer Res. Treat 2009, 116:479-489.
19. Kuilman T., Velds A., Kemper K., Ranzani M., Bombardelli L., Hoogstraat M., Nevedomskaya E., Xu G., de Ruiter J., Lolkema M.P., Ylstra B., Jonkers J., Rottenberg S., Wessels L.F., Adams D.J., Peeper D.S., Krijgsman O. CopywriteR: DNA copy number detection from off-target sequence data. Genome Biology 2015, 16:49. 10.1186/s13059-015-0617-1.
20. Krijgsman O., Israeli D., Haan J.C., van Essen H.F., Smeets S.J., Eijk P.P., Steenbergen R.D.M., Kok K., Tejpar S., Meijer G.A., Ylstra B. CGH arrays compared for DNA isolated from formalin-fixed, paraffin-embedded material. Genes Chromosomes Cancer 2012, 51:344-352.
21. Li H., Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinforma. Oxf. Engl. 2009, 25:1754-1760.
22. Lips E.H., Mulder L., Hannemann J., Laddach N., Vrancken Peeters M.T.F.D., van de Vijver M.J., Wesseling J., Nederlof P.M., Rodenhuis S. Indicators of homologous recombination deficiency in breast cancer and association with response to neoadjuvant chemotherapy. Ann. Oncol. 2011, 22:870-876.
23. Natrajan R., Lambros M.B., Rodríguez-Pinilla S.M., Moreno-Bueno G., Tan D.S.P., Marchió C., Vatcheva R., Rayter S., Mahler-Araujo B., Fulford L.G., Hungermann D., Mackay A., Grigoriadis A., Fenwick K., Tamber N., Hardisson D., Tutt A., Palacios J., Lord C.J., Buerger H., Ashworth A., Reis-Filho J.S. Tiling path genomic profiling of grade 3 invasive ductal breast cancers. Clin. Cancer Res. 2009, 15:2711-2722.
24. Natrajan R., Wilkerson P.M., Marchiò C., Piscuoglio S., Ng C.K.Y., Wai P., Lambros M.B., Samartzis E.P., Dedes K.J., Frankum J., Bajrami I., Kopec A., Mackay A., A'hern R., Fenwick K., Kozarewa I., Hakas J., Mitsopoulos C., Hardisson D., Lord C.J., Kumar-Sinha C., Ashworth A., Weigelt B., Sapino A., Chinnaiyan A.M., Maher C.A., Reis-Filho J.S. Characterization of the genomic features and expressed fusion genes in micropapillary carcinomas of the breast. J. Pathol. 2014, 232:553-565.
25. Nilsen G., Liestøl K., Van Loo P., Moen Vollan H.K., Eide M.B., Rueda O.M., Chin S.-F., Russell R., Baumbusch L.O., Caldas C., Børresen-Dale A.-L., Lingjaerde O.C. Copynumber: efficient algorithms for single- and multi-track copy number segmentation. BMC Genomics 2012, 13:591.
26. Picard F., Lebarbier E., Hoebeke M., Rigaill G., Thiam B., Robin S. Joint segmentation, calling, and normalization of multiple CGH profiles. Biostatistics 2011, 12:413-428.
27. Rodenhuis S., Bontenbal M., Beex L.V.A.M., Wagstaff J., Richel D.J., Nooij M.A., Voest E.E., Hupperets P., van Tinteren H., Peterse H.L., TenVergert E.M., de Vries E.G.E. High-dose chemotherapy with hematopoietic stem-cell rescue for high-risk breast cancer. N. Engl. J. Med. 2003, 349:7-16.
28. Schouten P.C., Marmé F., Aulmann S., Sinn H.-P., van Essen H.F., Ylstra B., Hauptmann M., Schneeweiss A., Linn S.C. Breast Cancers with a BRCA1-like DNA Copy Number Profile Recur Less Often Than Expected after High-Dose Alkylating Chemotherapy. Clin. Cancer Res. 2015, 21:763-770. 10.1158/1078-0432.CCR-14-1894.
29. Schouten P. Table1Heatmap 2014, http://cran.us.r-project.org/web/packages/Table1Heatmap/index.html.
30. Schouten P.C., van Dyk E., Braaf L.M., Mulder L., Lips E.H., de Ronde J.J., Holtman L., Wesseling J., Hauptmann M., Wessels L.F.A., Linn S.C., Nederlof P.M. Platform comparisons for identification of breast cancers with a BRCA-like copy number profile. Breast Cancer Res. Treat 2013, 139:317-327.
31. Schouten P., Gluz O., Harbeck N., Mohrmann S., Diallo-Danebrock R., Pelz E., Kruizinga J., Velds A., Nieuwland m, Kerkhoven R., Liedtke C., Frick M., Kates R., Linn S., Marme F. BRCA1-like copy number profiles to predict benefit of high-dose alkylating chemotherapy in high-risk breast cancer (BC): results from randomized WSG AM-01 trial. J. Clin. Oncol. 2014, 32(5s). (suppl; abstr 11018).
32. Schouten P., Linn S., Aulmann S., Sinn H., Schneeweiss A., Marme F. BRCA1 like copy number profiles to predict benefit of intensified alkylating chemotherapy in breast cancer. J. Clin. Oncol. 2013, 2013(suppl). abstr 11023.
33. Stevenson M. epiR: An R Package for the Analysis of Epidemiological Data 2012.
34. Tirkkonen M., Johannsson O., Agnarsson B.A., Olsson H., Ingvarsson S., Karhu R., Tanner M., Isola J., Barkardottir R.B., Borg A., Kallioniemi O.P. Distinct somatic genetic changes associated with tumor progression in carriers of BRCA1 and BRCA2 germ-line mutations. Cancer Res. 1997, 57:1222-1227.
35. Tung N., Miron A., Schnitt S.J., Gautam S., Fetten K., Kaplan J., Yassin Y., Buraimoh A., Kim J.-Y., Szász A.M., Tian R., Wang Z.C., Collins L.C., Brock J., Krag K., Legare R.D., Sgroi D., Ryan P.D., Silver D.P., Garber J.E., Richardson A.L. Prevalence and predictors of loss of wild type BRCA1 in estrogen receptor positive and negative BRCA1-associated breast cancers. Breast Cancer Res. 2010, 12:R95.
36. Turner N., Tutt A., Ashworth A. Hallmarks of "BRCAness" in sporadic cancers. Nat. Rev. Cancer 2004, 4:814-819.
37. Venkatraman E.S., Olshen A.B. A faster circular binary segmentation algorithm for the analysis of array CGH data. Bioinforma 2007, 23:657-663.
38. Venkitaraman A.R. Linking the cellular functions of BRCA genes to cancer pathogenesis and treatment. Annu. Rev. Pathol. 2009, 4:461-487.
39. Vermaat J.S., Nijman I.J., Koudijs M.J., Gerritse F.L., Scherer S.J., Mokry M., Roessingh W.M., Lansu N., de Bruijn E., van Hillegersberg R., van Diest P.J., Cuppen E., Voest E.E. Primary colorectal cancers and their subsequent hepatic metastases are genetically different: implications for selection of patients for targeted treatment. Clin. Cancer Res. 2012, 18:688-699. 10.1158/1078-0432.CCR-11-1965.
40. Vollebergh M.A., Jonkers J., Linn S.C. Genomic instability in breast and ovarian cancers: translation into clinical predictive biomarkers. Cell. Mol. Life Sci. 2012, 69:223-245.
41. Vollebergh M.A., Klijn C., Schouten P.C., Wesseling J., Israeli D., Ylstra B., Wessels L.F.A., Jonkers J., Linn S.C. Lack of genomic heterogeneity at high-resolution aCGH between primary breast cancers and their paired lymph node metastases. PloS One 2014, 9:e103177.
42. Vollebergh M.A., Lips E.H., Nederlof P.M., Wessels L.F.A., Schmidt M.K., van Beers E.H., Cornelissen S., Holtkamp M., Froklage F.E., de Vries E.G.E., Schrama J.G., Wesseling J., van de Vijver M.J., van Tinteren H., de Bruin M., Hauptmann M., Rodenhuis S., Linn S.C. An aCGH classifier derived from BRCA1-mutated breast cancer and benefit of high-dose platinum-based chemotherapy in HER2-negative breast cancer patients. Ann. Oncol. 2011, 22:1561-1570.
43. Wang Y., Moorhead M., Karlin-Neumann G., Falkowski M., Chen C., Siddiqui F., Davis R.W., Willis T.D., Faham M. Allele quantification using molecular inversion probes (MIP). Nucleic Acids Res. 2005, 33:e183.
44. Wessels L.F.A., van Welsem T., Hart A.A.M., van't Veer L.J., Reinders M.J.T., Nederlof P.M. Molecular classification of breast carcinomas by comparative genomic hybridization: a specific somatic genetic profile for BRCA1 tumors. Cancer Res. 2002, 62:7110-7117.
45. Wicker N., Carles A., Mills I.G., Wolf M., Veerakumarasivam A., Edgren H., Boileau F., Wasylyk B., Schalken J.A., Neal D.E., Kallioniemi O., Poch O. A new look towards BAC-based array CGH through a comprehensive comparison with oligo-based array CGH. BMC Genomics 2007, 8:84.